AIC649 is an inactivated parapoxvirus ovis (iPPVO) particle preparation with distinct immunological activities including regulated cytokine release and activation of T-cell responses.
Meet AiCuris at J.P. Morgan 34th Annual Healthcare Conference 2016 January 11-14 in San Francisco, CA, USA.
The annual meeting of BioDeutschland took place in Hannover on Monday, 5th of October. Part of the meeting was also the election of a new board for the next two years.
The BEAM Alliance (Biopharmaceutical companies from Europe innovating in Anti-Microbial resistance research) today announces the release of its position paper.
The IMI-funded COMBACTE-MAGNET-consortium announced the start of a retrospective epidemiological study in autumn 2015
Prof. Helga RĂĽbsamen-Schaeff, founding CEO and as of March Chair of the Scientific Advisory Board of Wuppertal-based Biotech AiCuris has been honored with the "IUPAC 2015 Distinguished Women in Chemistry or Chemical Engineering Award".
AiCuris is one of the founding members of the newly launched alliance of Biotechs of Europe innovating in Anti-Microbial Resistanceâ€ť, called the BEAM Alliance.
Dr. Manickam Rangaraju joined AiCuris on 1st May 2015 as new Head of Development, responsible for all preclinical and clinical activities of the company. Already one month before Dr. Alexander Birkmann had taken over the position as Head of Research.
Today 33 European academic partners and 5 pharmaceutical companies are launching a new project, COMBACTE-MAGNET, under the IMI antimicrobial resistance research programme New Drugs 4 Bad Bugs (ND4BB).
After 9 very successful years establishing and developing Wuppertal-based biotech company AiCuris, Prof. Dr. Helga RĂĽbsamen-Schaeff will transition from her function as CEO to assume the role of Chair of the Board, as of March 1st 2015.
The 2014 IUPAC-Richter Prize in Medicinal Chemistry has been awarded to AiCuris' Head of Chemistry & Patents, Dr. Helmut Buschmann.
If you have a media enquiry or further questions regarding public relation activities at AiCuris please contact us.